Global Genomics Market Size, Share & Trends Analysis Report by Deliverable (Product, and Services), by Technology (Sequencing, PCR, Nucleic Acid Extraction and Purification, Microarray, and Other) by Application (Drug Discovery and Development, Diagnostics, Agriculture and Animal Research, and Other), and by End-User (Hospitals & Clinics, Academic and Research Centers, Pharmaceutical & Biotechnology Companies, and Other), Forecast Period (2022-2028) The global genomics market is anticipated to grow at a CAGR of 15.3% during the forecast period. The increasing new technology introduction in the products and development process with the innovation is a key factor driving the growth of the market. For instance, in January 2022, Sema4 acquired GeneDx, Inc. (OPKO Health, Inc.) to strengthen Sema4’s 12 million de-identified clinical records. The company has planned to leverage the "Centrellis & Traversa" combined health information database for the transformation of patient care and therapeutic development and enable precision medicine. The global genomics market is segmented based on the deliverable, technology, application, and end-user. Based on the type, the market is segmented into products and services. Based on the technology, the market is segmented into sequencing, PCR, nucleic acid extraction and purification, microarray, and others. Based on the application, the market is subdivided into drug discovery and development, diagnostics, agriculture and animal research, and others. Based on the end-user, the market is subdivided into hospitals & clinics, academic and research centers, pharmaceutical & biotechnology companies, and others. Among the deliverable segment product segment is anticipated to hold a prominent share in the market owing to increasing and continually new launches of reagents and kits, and increasing prominent players in the market are adopting several strategies such factors drive market growth. For instance, in June 2020, Omega Bio-tek, Inc., launched the Mag-Bind Viral RNA Xpress Kit for the rapid and reliable isolation of Viral RNA from nasopharyngeal (NP) in viral transport media (VTM). The new kit is being developed to combat the shortage of RNA purification kits that are used in COVID-19 testing. Geographically genomics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America region is predicted to hold a prominent share in the market owing to the growing number of research programs, increasing regulatory approval, grants by government authorities and regulatory bodies, and changing regulations for reimbursement are such factors that drive the market growth. For instance, in April 2020, Genome Canada launched the Canadian COVID Genomics Network (CanCOGeN) with the funding of $40 million with partnership in six regional Genome Centers, national and provincial public health labs, genome sequencing centers through CGEn, hospitals, universities and the private sector. This new funding was set to coordinate and scale up existing genomics-based COVID-19 research in Canada to accelerate public impact internationally. Moreover, the growing burden of chronic diseases, increasing demand for R&D investments, and increasing strategic partnerships by key industry players to offer effective genomics solutions are other such factors that drive regional market growth. The major companies serving the global genomics market include Agilent Technologies, Inc., Danaher Corp., Eurofins Scientific Ltd., F. Hoffmann-La Roche Ltd., Illumina Inc., Quest Diagnostics, Thermo Fisher Scientific, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, geographical expansions, partnerships, product launches, and collaborations, to stay competitive in the market. For instance, in August 2021, Genome Medical acquired GeneMatters, to accelerate commercial traction and advance for transforming health care for all through genomic medicine. This new acquisition company is made to preeminent technology-enabled provider of genetic health services and genomic insights. The company uses the financing proceeds to expand its team and further enhance the development of its configurable technology solutions that will provide innovative and efficient genomic medicine programs. Research Methodology The market study of the global Genomics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports. Secondary Sources Include • Financial reports of companies involved in the market. • Whitepapers, research papers, and news blogs. • Company websites and their product catalog. The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models. Market Segmentation 1. Global Genomics Market Research and Analysis by Deliverable 2. Global Genomics Market Research and Analysis by Technology 3. Global Genomics Market Research and Analysis by Application 4. Global Genomics Market Research and Analysis by End-User The Report Covers • Comprehensive research methodology of the global genomics market. • This report also includes a detailed and extensive market overview with key analyst insights. • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. • Analysis of regional regulations and other government policies impacting the global genomics market. • Insights about market determinants that are stimulating the global genomics market. • Detailed and extensive market segments with the regional distribution of forecasted revenues. • Extensive profiles and recent developments of market players.